Panaxia Labs Israel Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was ILS 19.59 million compared to ILS 39.42 million a year ago. Net loss was ILS 13.4 million compared to ILS 43.27 million a year ago.

Basic loss per share from continuing operations was ILS 0.89 compared to ILS 290 a year ago.